Waters Corporation Announces Beating Their Estimate by $0. 06 in Third Quarter Non-GAAP EPS
November 18, 2022
Trending News 🌧️
Waters Corporation ($NYSE:WAT) is a leading global provider of analytical solutions for customers in the life sciences, industrial, and environmental markets. The company designs, manufactures, sells, and services high-performance liquid chromatography, ultra-performance liquid chromatography, and mass spectrometry systems and support products. Waters Corporation announced their third quarter non-GAAP EPS of $2. 06.
This is a great accomplishment for the company and investors are sure to be pleased. The company attributes the success to their strong product portfolio and continued focus on operational excellence. Waters Corporation is committed to delivering innovative solutions that enable scientists and engineers to meet their goals and make the world a healthier, cleaner place.
Earnings
The company reported total revenue of $2900.6 million and net income of $702.1 million. Compared to the previous year, this represents a 4.1% increase in total revenue and a 1.3% increase in net income. Waters Corporation‘s total revenue has grown from $2365.4 million to $2900.6 million over the last three years. The company has been able to achieve this growth despite challenging macroeconomic conditions. Waters Corporation attributes its success to its strong portfolio of products and its disciplined execution.
Market Price
This news sent their stock prices soaring, with the stock opening at $303.9 and closing at $307.4, up 2.8% from the previous close of $299.2. This is great news for Waters Corporation, as they have been struggling recently. This boost in EPS is a sign that the company is on the right track and that their efforts to improve their financial situation are paying off. We expect to see their stock prices continue to rise as investors become more confident in the company’s future.
VI Analysis
Waters Corporation is a strong company with regards to its cashflows and debt. It is capable of sustaining future operations in times of crisis.
However, it is weak in terms of profitability, growth, and asset. dividend. It is classified as ‘rhino’, a type of company that has achieved moderate revenue or earnings growth. What type of investors may be interested in such a company? Investors who are interested in companies that are strong in cashflows and debt, and capable of sustaining future operations in times of crisis, may be interested in Waters Corporation.
VI Peers
Waters Corporation is an American analytical instrument manufacturing company that specializes in liquid chromatography, mass spectrometry, and thermal analysis instruments. It has annual sales of over $2 billion and employs more than 6,000 people worldwide. Its products are used in the life sciences, pharmaceutical, and chemical industries. Waters Corporation’s main competitors are IQVIA Holdings Inc, Agilent Technologies Inc, Vijaya Diagnostic Centre Ltd.
– IQVIA Holdings Inc ($NYSE:IQV)
The company’s market cap as of 2022 was 39.27B and its ROE was 21.52%. The company is a global provider of information, innovative technology solutions, and real-world insights that help customers improve their well-being. The company offers a broad range of products and services that enable customers to manage their health and wellbeing.
– Agilent Technologies Inc ($NYSE:A)
Agilent Technologies, Inc. is a provider of life sciences, diagnostics, and applied chemical markets solutions. It operates through three segments: Life Sciences and Applied Markets Group, Diagnostics and Genomics Group, and Agilent CrossLab Group. The Life Sciences and Applied Markets Group segment offers application solutions that include chromatography, mass spectrometry, chemical analysis, and cellular analysis. The Diagnostics and Genomics Group segment provides in vitro diagnostic products and services. The Agilent CrossLab Group segment offers a range of services and consumables. Agilent Technologies was founded in 1999 and is headquartered in Santa Clara, California.
– Vijaya Diagnostic Centre Ltd ($BSE:543350)
Vijaya Diagnostic Centre Ltd is a leading diagnostic centre in India with a market cap of 46.61B as of 2022. The company has a return on equity of 17.7%. The company offers a wide range of diagnostic services including X-rays, ultrasounds, MRI, and CT scans. The company also has a wide network of centres across India.
Summary
Waters Corporation is a publicly traded company that manufactures and sells scientific instruments, software, and services used in chromatography, mass spectrometry, and thermal analysis. The company has a market capitalization of over $10 billion and trades on the New York Stock Exchange under the ticker symbol WAT. Investors may want to consider Waters Corporation as a potential investment because of the company’s strong financial position and market leading position in its industry. Some risks to consider before investing include the potential for regulatory changes that could impact the company’s business, and the reliance on a small number of key customers.
Recent Posts









